Innovations
One of the reasons why it is important to bring innovations to the citizens of the community is that it is unacceptable that it should take 17 years in funding for an innovation to reach patients and our focus was to reduce this to a minimum.
Faster research results for the public
At the Department of Immunotechnology, we have been working with this since 1983 when we scouted out our first company - BioInvent, working on antibody-based cancer therapy, so-called targeted therapy. Moreover, the translational cancer center CREATE Health (started in 2005) has the mantra "cancer innovations not for tomorrow's generations but already for today's!"
Spin-off companies
The awareness that the boundary between basic and applied research has largely been blurred within biomedical research has led us to early identification of innovation that could have a crucial impact on patients. This has resulted in the Department being founded and being part founder of a number of companies in life sciences, exemplified by companies such as Alligator Bioscience AB, Immunovia AB, SenzaGen AB, PainDrainer AB, and many more.
Record donation to cancer research
In 2025, the Mrs Berta Kamprad Foundation donated SEK 420 million to cancer research at Lund University. This is the largest donation to the university since its foundation in 1666. The administrative recipient was CREATE Health Translational Cancer Centre.